SCHEMBL31174103

SCHEMBL31174103

COc1cc(-c2c(-n3cc(Cl)nn3)ccc(Cl)c2F)ccn1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ F11 P03951 5/20 0.40
▸ KLKB1 P03952 2/20 0.38
▸ F2 P00734 1/20 0.38
▸ RXRA P19793 5/20 0.35
▸ GRIN1 Q05586 5/20 0.35
▸ GRIN2B Q13224 5/20 0.35
▸ ADORA2B P29275 1/20 0.34
▸ ACVR2A P27037 2/20 0.34
▸ TGFBR2 P37173 2/20 0.34
▸ CLK1 P49759 1/20 0.33
▸ DYRK1A Q13627 1/20 0.33
▸ GRM5 P41594 1/20 0.33
▸ NOTUM Q6P988 1/20 0.33
▸ GRM2 Q14416 1/20 0.32
▸ TDO2 P48775 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ GABRA1 P14867 1/20 0.32
▸ GABRG2 P18507 1/20 0.32
▸ GABRB3 P28472 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31174090 0.88 NOTUM (0.45) F11KLKB1F2RXRAGRIN1
SCHEMBL29227936 0.87 F11 (0.41) F11KLKB1RXRAGRIN1GRIN2B
SCHEMBL30995051 0.87 F11 (0.41) F11KLKB1RXRAGRIN1GRIN2B
SCHEMBL31174106 0.85 NOTUM (0.47) F11NOTUMGRM2
SCHEMBL16971357 0.83 F11 (0.37) F11KLKB1F2RXRAGRIN1
SCHEMBL24633365 0.78 F11 (0.43) F11KLKB1ACVR2ATGFBR2
SCHEMBL30995011 0.78 F11 (0.43) F11KLKB1ACVR2ATGFBR2
SCHEMBL16974697 0.75 NOTUM (0.43) F11RXRAGRIN1GRIN2BNOTUM
SCHEMBL30995035 0.74 ADORA2B (0.45) ADORA2BACVR2ATGFBR2DYRK1AGRM5
SCHEMBL16971893 0.74 NOTUM (0.40) F11KLKB1F2RXRAGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118852163-A Macrocyclic compound containing heteroatoms, and preparation method and application thereof 深圳信立泰药业股份有限公司 2024-10-29 — — CN disclosed
Send feedback